眼部保健补充剂市场规模、份额、成长分析（按成分类型、适应症、配方、分销管道和地区）—2025-2032 年行业预测

2023 年眼部保健补充剂市场规模价值 25 亿美元，预计将从 2024 年的 26.7 亿美元增长到 2032 年的 44.8 亿美元，预测期内（2025-2032 年）的复合年增长率为 6.7%。

由于视力障碍和近视的盛行率不断上升，尤其是在 COVID-19 疫情期间萤幕时间的增加，眼部保健补充剂市场正在经历显着增长。白内障、青光眼和老龄化黄斑部病变（AMD）等疾病正变得越来越普遍，尤其是在老化人口数位原民代千禧世代。特别是，根据世界卫生组织（WHO）的报告，全球约有22亿人患有视力问题，中低收入国家受到的影响尤其严重。随着已开发国家消费支出的成长，对叶黄素、玉米黄质和其他补充剂的需求不断增长，进一步推动了市场的扩张。由于转向线上销售管道，眼部补充剂的电子商务销售额最近增长了近48.3％，巩固了美国市场的积极成长轨迹。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究
• 技术分析

眼部保健补充剂市场规模（按成分类型和复合年增长率） (2025-2032)

• 市场概览
• 叶黄素和玉米黄质
• 抗氧化剂
• Omega-3脂肪酸
• Coenzyme Q10
• 黄酮类化合物
• 硫辛酸
• 虾青素
• 其他的

眼部保健补充剂市场规模（按适应症和复合年增长率） (2025-2032)

• 市场概览
• 老龄化黄斑部病变（AMD）
• 白内障
• 干眼症
• 发炎
• 其他的

眼部保健补充剂市场规模（按配方和复合年增长率） (2025-2032)

• 市场概览
• 药片
• 胶囊
• 粉末
• 软胶囊
• 液体
• 其他的

眼部保健品市场规模（依通路及复合年增长率）(2025-2032)

• 市场概览
• 医院药房
• 零售药局
• 大卖场和超级市场
• 电子商务

眼部保健品市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Santen Pharmaceutical（Japan）
• Rohto Pharmaceutical（Japan）
• Dompe Farmaceutici（Italy）
• Vianex SA（Greece）
• Abbott Laboratories（USA）
• Bausch+Lomb（USA）
• Alcon（Switzerland）
• Pfizer Inc.（USA）
• Novartis AG（Switzerland）
• Thea Pharma（France）
• Similasan AG（Switzerland）
• Jamieson Wellness（Canada）
• Nature's Way（USA）
• NOW Foods（USA）
• Nature's Bounty（USA）
• GNC Holdings（USA）
• Herbalife Nutrition（USA）
• Amway（USA）
• Pharma Nord（Denmark）
• Solgar（USA）

结论和建议

Eye Health Supplements Market size was valued at USD 2.5 billion in 2023 and is poised to grow from USD 2.67 billion in 2024 to USD 4.48 billion by 2032, growing at a CAGR of 6.7% during the forecast period (2025-2032).

The eye health supplements market is experiencing significant growth driven by the increasing prevalence of vision impairment and myopia, particularly exacerbated by heightened screen time during the COVID-19 pandemic. Conditions such as cataracts, glaucoma, and age-related macular degeneration (AMD) are becoming more common, especially among the aging population and digital-native millennials. Notably, the World Health Organization reports that approximately 2.2 billion people globally struggle with vision issues, with a disproportionate impact in low to middle-income countries. Rising consumer spending in developed nations, alongside the growing demand for Lutein, Zeaxanthin, and other supplements, further propels market expansion. The shift towards online sales channels has significantly increased accessibility, with e-commerce sales of eye supplements up nearly 48.3% recently, reinforcing a positive growth trajectory for the U.S. eye health supplements market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Eye Health Supplements market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Eye Health Supplements Market Segments Analysis

Global Eye Health Supplements Market is segmented by Ingredient Type, Indication, Formulation, Distribution Channel and region. Based on Ingredient Type, the market is segmented into Lutein & Zeaxanthin, Antioxidants, Omega-3 Fatty Acids, Coenzyme Q10, Flavonoids, Alpha-Lipoic Acid, Astaxanthin and Others. Based on Indication, the market is segmented into Age-related Macular Degeneration (AMD), Cataract, Dry Eye Syndrome, Inflammation and Others. Based on Formulation, the market is segmented into Tablets, Capsules, Powder, Softgels, Liquid and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, Hypermarkets & Supermarkets and E-Commerce. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Eye Health Supplements Market

The increasing occurrence of eye-related conditions, including age-related macular degeneration (AMD), cataracts, and dry eye syndrome, is fueling the demand for eye health supplements. With a rapidly aging global population, the prevalence of these disorders is anticipated to grow, leading to an expanding market for supplements designed to promote and maintain eye health. As individuals become more aware of the importance of eye care, there is a greater inclination towards preventative measures, further driving the need for effective eye health supplements. This trend highlights the significant opportunity within the market as consumers seek to protect their vision and overall ocular well-being.

Restraints in the Eye Health Supplements Market

The Eye Health Supplements market faces a significant restraint due to the limited scientific evidence surrounding their effectiveness and long-term consequences. Although anecdotal accounts and some preliminary research suggest potential benefits, the absence of comprehensive clinical studies and consistent research methodologies poses a challenge. This inadequacy can undermine consumer trust and willingness to embrace these products, as many individuals may hesitate to invest in supplements when the scientific backing is not sufficiently robust. Consequently, the market may struggle to gain traction as consumers seek more credible information before making purchasing decisions related to eye health supplements.

Market Trends of the Eye Health Supplements Market

The Eye Health Supplements market is witnessing a significant trend driven by increasing consumer awareness regarding ocular wellness and the prevention of age-related conditions like macular degeneration and cataracts. As more individuals embrace proactive health management, the demand for eye health supplements is surging, with consumers incorporating these products into their daily wellness routines to support optimal vision and overall eye function. This trend is further fueled by the proliferation of information on the benefits of nutrients like lutein, zeaxanthin, and omega-3 fatty acids, positioning eye health supplements as essential components of holistic health strategies in an increasingly health-conscious market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technology Analysis

Global Eye Health Supplements Market Size by Ingredient Type & CAGR (2025-2032)

• Market Overview
• Lutein & Zeaxanthin
• Antioxidants
• Omega-3 Fatty Acids
• Coenzyme Q10
• Flavonoids
• Alpha-Lipoic Acid
• Astaxanthin
• Others

Global Eye Health Supplements Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Age-related Macular Degeneration (AMD)
• Cataract
• Dry Eye Syndrome
• Inflammation
• Others

Global Eye Health Supplements Market Size by Formulation & CAGR (2025-2032)

• Market Overview
• Tablets
• Capsules
• Powder
• Softgels
• Liquid
• Others

Global Eye Health Supplements Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacy
• Retail Pharmacy
• Hypermarkets & Supermarkets
• E-Commerce

Global Eye Health Supplements Market Size & CAGR (2025-2032)

• North America (Ingredient Type, Indication, Formulation, Distribution Channel)
  • US
  • Canada
• Europe (Ingredient Type, Indication, Formulation, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Ingredient Type, Indication, Formulation, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Ingredient Type, Indication, Formulation, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Ingredient Type, Indication, Formulation, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Santen Pharmaceutical (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rohto Pharmaceutical (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dompe Farmaceutici (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vianex S.A. (Greece)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch + Lomb (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alcon (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thea Pharma (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Similasan AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jamieson Wellness (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nature's Way (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NOW Foods (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nature's Bounty (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GNC Holdings (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Herbalife Nutrition (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amway (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharma Nord (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Solgar (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations